anticancer compound library

A unique collection of 9332 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 2680 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 3230 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 800 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 659 natural terpenes and terpenoids can be used for high throughput and high content screening;

The unparalleled chemical diversity of natural products makes them an ideal choice for screening active small molecules. Natural products is always a significant source in drug discovery. According to authoritative statistics, 79 out of 99 small molecule anticancer drugs have been successfully developed based on natural products since 1981. Natural products have demonstrated successful modulation of isolated but crucial targets, especially in antimicrobial targets and protein interactions. Many researchers consider natural products and their derivatives as unique tools for studying and manipulating protein function. The Drug-like Natural Compound Library comprises 522 novel molecules, serving as a complement to the L6000 Natural Product Library. This library enhances the probability of successful drug screening, making it an excellent tool for lead compound discovery.

A unique collection of 142 microtubule-targeted compounds can be used in HTS and HCS;

A unique collection of 1800 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);

A unique collection of 3970 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);